NASDAQ:NH - NantHealth Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.54 -0.01 (-1.82 %) (As of 05/24/2019 05:17 AM ET)Previous Close$0.55Today's Range$0.52 - $0.5552-Week Range$0.48 - $3.64Volume34,500 shsAverage Volume262,327 shsMarket Capitalization$59.36 millionP/E RatioN/ADividend YieldN/ABeta0.99 ProfileAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email NantHealth, Inc., together with its subsidiaries, operates as a healthcare technology company in the United States and internationally. The company engages in converging science and technology through an integrated clinical platform to provide health information at the point of care. It develops NantHealth solutions, including molecular profiling solutions, software, and hardware systems infrastructure, which integrates patient data management, bioinformatics, and molecular medicine to enable value-based care and evidence-based clinical practice. The company's products include GPS Cancer, a molecular profile that integrates whole genome sequencing of tumor and normal germline samples, as well as whole transcriptome sequencing; GPS Cancer Report, a GPS cancer solution; GPS in rare diseases and chronic illnesses; Liquid GPS, a blood-based molecular test; and Eviti, a decision support solution. It also provides Web-based and mobile software solutions, such as Device Connectivity Suite, a device connectivity and near real-time biometric software and hardware suite; DeviceConX, a device data normalization software; HBox, an Internet of Medical Things and Internet of Things hardware hub; and VitalsConX, a tablet-optimized application. In addition, NantHealth, Inc. offers NaviNet Open, a payer-provider collaboration platform comprising plan central, eligibility and benefit, claims status inquiry, claims management, referral, authorization, document exchange, and AllPayer services; and cloud-based computing, storage, and transport infrastructure-as-a-service solutions. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was founded in 2010 and is headquartered in Culver City, California. NantHealth, Inc. is as a subsidiary of NantWorks, LLC. Receive NH News and Ratings via Email Sign-up to receive the latest news and ratings for NH and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Data processing & preparation Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:NH Previous SymbolNYSE:NH CUSIPN/A CIK1566469 Webhttp://www.nanthealth.com/ Phone310-883-1300Debt Debt-to-Equity Ratio70.81 Current Ratio0.87 Quick Ratio0.86Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$89.46 million Price / Sales0.66 Cash FlowN/A Price / Cash FlowN/A Book Value($0.15) per share Price / Book-3.60Profitability EPS (Most Recent Fiscal Year)($1.74) Net Income$-192,150,000.00 Net Margins-208.85% Return on Equity-405.21% Return on Assets-57.87%Miscellaneous Employees543 Outstanding Shares109,931,000Market Cap$59.36 million Next Earnings Date8/8/2019 (Estimated) OptionableOptionable NantHealth (NASDAQ:NH) Frequently Asked Questions What is NantHealth's stock symbol? NantHealth trades on the NASDAQ under the ticker symbol "NH." How were NantHealth's earnings last quarter? NantHealth Inc (NASDAQ:NH) issued its quarterly earnings results on Thursday, May, 9th. The company reported ($0.18) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.10) by $0.08. The company earned $23.73 million during the quarter, compared to analyst estimates of $23.90 million. NantHealth had a negative net margin of 208.85% and a negative return on equity of 405.21%. View NantHealth's Earnings History. When is NantHealth's next earnings date? NantHealth is scheduled to release their next quarterly earnings announcement on Thursday, August 8th 2019. View Earnings Estimates for NantHealth. What is the consensus analysts' recommendation for NantHealth? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NantHealth in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for NantHealth. Has NantHealth been receiving favorable news coverage? Media stories about NH stock have trended neutral on Friday, InfoTrie Sentiment reports. InfoTrie rates the sentiment of press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. NantHealth earned a media sentiment score of 0.3 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the next several days. Who are some of NantHealth's key competitors? Some companies that are related to NantHealth include Ooma (OOMA), Phunware (PHUN), Veritone (VERI), FRONTEO (FTEO), Park City Group (PCYG), Renren (RENN), Intersections (INTX), MTECH ACQUISITI/SH CL A (MTEC), Longfin (LFIN), Support.com (SPRT), iPass (IPAS), Innodata (INOD), Data Storage (DTST), Marin Software (MRIN) and Net Element (NETE). What other stocks do shareholders of NantHealth own? Based on aggregate information from My MarketBeat watchlists, some companies that other NantHealth investors own include Nantkwest (NK), Trevena (TRVN), Progenics Pharmaceuticals (PGNX), Akorn (AKRX), Corbus Pharmaceuticals (CRBP), Idera Pharmaceuticals (IDRA), SCYNEXIS (SCYX), Zynerba Pharmaceuticals (ZYNE), Advaxis (ADXS) and Achaogen (AKAO). Who are NantHealth's key executives? NantHealth's management team includes the folowing people: Dr. Patrick Soon-Shiong F.A.C.S., FRCS (C), M.D., FACS, Founder, Chairman & CEO (Age 66)Mr. Ronald Allen Louks, COO & Director (Age 54)Mr. Bob Petrou, Interim Chief Financial Officer (Age 47)Mr. Brandon Villery, VP, Gen. Counsel & Corp. Sec.Mr. Charles Hunt, VP of Marketing, Communications & User Experience When did NantHealth IPO? (NH) raised $91 million in an initial public offering on Thursday, June 2nd 2016. The company issued 6,500,000 shares at $12.50-$15.50 per share. Jefferies and Cowen and Company served as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers. Who are NantHealth's major shareholders? NantHealth's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (0.95%), JPMorgan Chase & Co. (0.27%), Jacobs Levy Equity Management Inc. (0.16%), Renaissance Technologies LLC (0.14%), Dimensional Fund Advisors LP (0.07%) and Miracle Mile Advisors LLC (0.03%). View Institutional Ownership Trends for NantHealth. Which institutional investors are selling NantHealth stock? NH stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., BlackRock Inc. and Dimensional Fund Advisors LP. View Insider Buying and Selling for NantHealth. Which institutional investors are buying NantHealth stock? NH stock was bought by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Jacobs Levy Equity Management Inc. and Miracle Mile Advisors LLC. View Insider Buying and Selling for NantHealth. How do I buy shares of NantHealth? Shares of NH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is NantHealth's stock price today? One share of NH stock can currently be purchased for approximately $0.54. How big of a company is NantHealth? NantHealth has a market capitalization of $59.36 million and generates $89.46 million in revenue each year. The company earns $-192,150,000.00 in net income (profit) each year or ($1.74) on an earnings per share basis. NantHealth employs 543 workers across the globe. What is NantHealth's official website? The official website for NantHealth is http://www.nanthealth.com/. How can I contact NantHealth? NantHealth's mailing address is 9920 JEFFERSON BLVD, CULVER CITY CA, 90232. The company can be reached via phone at 310-883-1300 or via email at [email protected] MarketBeat Community Rating for NantHealth (NASDAQ NH)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 224 (Vote Outperform)Underperform Votes: 236 (Vote Underperform)Total Votes: 460MarketBeat's community ratings are surveys of what our community members think about NantHealth and other stocks. Vote "Outperform" if you believe NH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NH will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/24/2019 by MarketBeat.com StaffFeatured Article: How mutual funds make money Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.